GlassScriptPhysician profile
Tingting Jiang
NPI 1174920060
$4,903.20
in general payments reported to CMS, 2019-2025
9 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,391 · 2022: $906 · 2023: $53.17 · 2024: $224 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $606.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,028.70 | 2021-2025 | |
| Allergan, INC. | $350.00 | 2021 | |
| Lilly USA, LLC | $179.33 | 2021-2024 | Kisunla |
| Genentech USA, INC. | $126.68 | 2025 | Ocrevus |
| Eisai INC. | $113.26 | 2024 | |
| Illumina, INC. | $45.69 | 2025 | Oncology Testing |
| Exact Sciences Corporation | $23.73 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $19.86 | 2025 | Krystexxa |
| Janssen Pharmaceuticals, INC | $15.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tingting Jiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.